Connect with us

Business

Novo Nordisk: The Pill That Could Close The Gap With Lilly (NYSE:NVO)

Published

on

Novo Nordisk: The Pill That Could Close The Gap With Lilly (NYSE:NVO)

This article was written by

I’m a lifelong entrepreneur who, alongside my other ventures, has always made time for the markets. Driven by genuine passion, I’ve been active with varying intensity for roughly 30 years, gaining perspective across multiple market cycles. I’ve built a company from scratch and operated as an entrepreneur in the food industry, lodging, and real estate, which has given me a strong, ground‑level understanding of how businesses really work. Because of that background, I always see the company behind the stock, and I like to keep the narrative and the numbers connected.The first twenty years of my market experience ran in parallel with other ventures — at times more like a hobby — but the last decade has been fully focused on the markets. Having gone through the 2000s dot‑com bubble and the 2008 subprime crisis with real skin in the game, I see both as extremely valuable lessons. I genuinely believe you learn far more from painful mistakes than from easy wins.In recent years I’ve experimented with different trading strategies, mostly built around options. I’ve won big and lost big, and in the process gained a much‑needed understanding of what prudent risk management really means — and how painful it is when it’s not implemented well. Even when I take more risk on the trading side, I keep my long‑term buy‑and‑hold positions completely separate from trading assets.My academic background is in Economics, and I’ve recently refreshed that foundation through a course aligned with the CFA curriculum, focused on securities valuation and risk management. I’m a believer in lifelong learning — it keeps you connected to new theories and how they’re applied. At the same time, I take Jesse Livermore’s century‑old, simple market truths as a core part of how I interpret everyday market behavior. I find real value in combining academic structure with Livermore‑style simple rules to gain a better understanding of the bigger picture.My passion is finding mispriced assets or situations the market may be overlooking or misinterpreting. With a deep interest in history and geopolitics, I tend to look at situations from a broader perspective. And when making investment bets, I like to keep in mind the old Gretzky quote: “I skate to where the puck is going to be, not where it has been.”

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Johnson & Johnson Stock: Buy IMAAVY Label Expansion First CAPLYTA Sales Push (NYSE:JNJ)

Published

on

Johnson & Johnson Stock: Buy IMAAVY Label Expansion First CAPLYTA Sales Push (NYSE:JNJ)

This article was written by

Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science background to generate long term value from Healthcare. He is the author of the investing group Biotech Analysis Central which contains a library of 600+ Biotech investing articles, a model portfolio of 10+ small and mid-cap stocks with deep analysis for each, live chat, and a range of analysis and news reports to help Healthcare investors make informed decisions.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

JEPQ: If You Must Own A NASDAQ 100 Covered Call Fund, It Should Not Be This One

Published

on

JEPQ: If You Must Own A NASDAQ 100 Covered Call Fund, It Should Not Be This One

JEPQ: If You Must Own A NASDAQ 100 Covered Call Fund, It Should Not Be This One

Continue Reading

Business

Oil Prices Extend Their Rally

Published

on

Ryan Dezember hedcut

Benchmark U.S. oil futures added 6.9%, or $5.59 a barrel to end the week at $87.06. They’ve traded higher for six consecutive sessions, 11 of the past 12 and are now about 37% higher than a year ago.

Brent crude futures, a global price gauge, rose Friday to settle at $94.39 a barrel.

The U.S. average retail price of a gallon of regular unleaded gasoline ended the week at about $4.10, according to Dow Jones Energy. National average diesel prices pushed closer to their May highs, hitting $5.57 a gallon on Friday.

Continue Reading

Business

Nvidia Stock: What To Expect From Nvidia’s Q2 Report

Published

on

Nvidia Stock: What To Expect From Nvidia’s Q2 Report

Nvidia (NVDA) stock has been on an odyssey since reaching an all-time high in mid-May. Since then, it has been blown off course by concerns of an artificial intelligence bubble, competing offerings and worries about circular financing deals with customers. The Santa Clara, Calif.-based company will get a chance to calm the seas with its fiscal second-quarter report, due late…

Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

Impinj Stock: Tracking-Chip Maker Set To Revolutionize Logistics

Published

on

Impinj Stock: Tracking-Chip Maker Set To Revolutionize Logistics

Impinj (PI), a maker of chips and systems for tracking inventory and assets, has been publicly traded for 10 years. But it is only just getting started in its growth trajectory, its chief executive says. Impinj stock received a fresh buy rating late Thursday. “We’re still sub-1% penetrated in a gigantic opportunity, initially started by retail apparel,” Chief Executive Chris…

Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

Motor racing- Palou claims seventh IndyCar pole of season in Washington

Published

on


Motor racing- Palou claims seventh IndyCar pole of season in Washington

Continue Reading

Business

Gold and Silver Mania Returns

Published

on

Gold and Silver Mania Returns

Treasury Secretary Scott Bessent’s bond market intervention this week lit a fire under gold and silver. Prices of the precious metals rose sharply again Friday. It’s a bit hard to square with rising bond yields, which makes holding precious metals a tough sell compared to just plonking the money in a savings account. But worries about America’s fiscal situation have a way of inspiring gold bugs.

Front-month gold futures added 5.6%, or $243.70 a troy ounce this week to settle Friday at $4,624.10. It was the third straight weekly gain for the precious metal, which has gained more than 14% over that span.

Silver futures, also on a three-week winning streak, rose even more. They gained 6.9% this week to end at $69.466 a troy ounce, the highest price since June 17.

Continue Reading

Business

Thank Moderna for the Healthcare Sector’s Standout Week

Published

on

Stocks Little Changed After Fed Decision

Thank Moderna for the Healthcare Sector’s Standout Week

Continue Reading

Business

Stock Market: Oil Shipping Name Hits New Highs; Three Stocks Also Near Pivots

Published

on

Stock Market: Oil Shipping Name Hits New Highs; Three Stocks Also Near Pivots

It is no surprise that crude oil shipper Frontline (FRO) has rallied to heady heights, with tensions over the Strait of Hormuz continuing to roil oil markets. But Investor’s Business Daily’s New Highs list is also springing a few surprises for investors, with a chip name, a biotech play, and a vehicle parts maker earning spots. A bonus? All four…

Copyright ©2026 Investor’s Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue Reading

Business

Mexican governor, indicted by US on cartel charges, requests leave again amid backlash

Published

on


Mexican governor, indicted by US on cartel charges, requests leave again amid backlash

Continue Reading

Trending

Copyright © 2025